Specialty Specific Guidance: An Endocrinologist’s Guide to Using GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight to Help Optimize Their Metabolic Health

by | Jan 15, 2026 | Endocrinology, Obesity Management

Patients who are living with obesity or overweight may seek care with an endocrinologist for other comorbidities, some of which may be directly linked to their weight. Weight reduction and management using pharmacotherapy, including GLP-1 RAs, can be a useful strategy...

Specialty Specific Guidance: An Orthopedic Surgeon’s Guide to Using GLP-1 Receptor Agonists in Patients who are Obese or Overweight to Optimize Joint Health and Surgical Outcomes

by | Jan 15, 2026 | Obesity Management, Orthopedic Surgery

Patients who are obese or overweight are more likely to require joint replacement surgery than their normal weight peers; however, higher BMIs also substantially increase the risks of orthopedic surgery. This increased risk often leads to orthopedic surgeons requiring...

Specialty Specific Guidance: An OB/GYN Professionals Guide to Using GLP-1 Receptor Agonists in Patients with Overweight or Obesity to Optimize Women’s Health Across the Lifespan

by | Jan 15, 2026 | Obesity Management, Obstetrics/Gynecology

Women frequently rely on their OB/GYN as their primary source of healthcare, particularly during their reproductive years. Many of these individuals may be living with overweight or obesity, placing the OB/GYN in a uniquely positioned and trusted role to support...